| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |